Market underwhelmed? That's possibly an understatement. Phase 1b...

Market underwhelmed? That's possibly an understatement. Phase 1b trials for BCC as I understand it are where they test for safety etc, only in phase 2 do they do trials for effectiveness...off in the medium/longer term one would think? Only about 18% phase 1b of clinical trials ever go to phase 2 so mr google tells me. Only just into phase 1b this quarter. Noted in qrtly financials they appear to have only spent about $800k out of the 1.4m allocation on research last quarter which seems like a trickle really, but shows 'active' research I guess. Patience is a vitue they say, as long as you're not too old to spend it.